Buys
Open market- Shares
- Avg price
- Total value
Octavio Espinoza - Chief Financial Officer at LIGAND PHARMACEUTICALS INC
Issuer-level insider activity
- Role
- Chief Financial Officer
- Issuer ticker
- LGND on Nasdaq, LGNDZ, LGNXZ, LGNYZ, LGNZZ on OTC
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Octavio Espinoza in LIGAND PHARMACEUTICALS INC
Sells
Open market- Shares
- -49,925
- Avg price
- $261.02
- Total value
- -$13,031,587
Net
Past year- Shares
- -49,925
- Share %
- -100%
- Total value
- -$13,031,587
Reported holdings for Octavio Espinoza in LIGAND PHARMACEUTICALS INC
Form 4 holding
Chief Financial Officer
LIGAND PHARMACEUTICALS INC
- Security class
- Common Stock
- Shares / value
- 27,696
- Estimated value
- $8,089,032
- Report date
- 12 Aug 2026
- Price
- $292.06
- Ownership
- Direct
Form 4 holding
Chief Financial Officer
LIGAND PHARMACEUTICALS INC
- Security class
- Employee Stock Option (right to buy)
- Shares / value
- 0
- Estimated value
- Report date
- 12 Aug 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Financial Officer
LIGAND PHARMACEUTICALS INC
- Security class
- Non-Qualified Stock Option (right to buy)
- Shares / value
- 0
- Estimated value
- Report date
- 12 Aug 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Octavio Espinoza in LIGAND PHARMACEUTICALS INC
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.